Brief: Egetis Therapeutics Q4 Loss Widens To SEK 77.8 Mln

Egetis Therapeutics AB (publ)

22/02/2023 06:10

Feb 22 (Reuters) - Egetis Therapeutics AB (publ)
 EGTX.ST :
    * YEAR-END REPORT Q4 2022
    * Q4 QUARTERLY REVENUES MSEK 5,7 (3,2)
    * Q4 LOSS MSEK -77,8 (-32,1)

Source text for Eikon:  ID:nMFN55gHsl 
Further company coverage:  EGTX.ST 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))